- 01A normal blood sugar does not rule out insulin resistance
In insulin resistance the pancreas makes more insulin to hold blood sugar steady, so fasting glucose and A1C stay normal for years. They rise only when the pancreas can no longer keep up. A high fasting insulin, a high HOMA-IR or a high triglyceride-to-HDL ratio can show the strain while glucose still looks fine.
- 02HOMA-IR has no single official cutoff
HOMA-IR is an estimate, not a diagnosis. One large population study put the insulin-resistant line anywhere from 1.85 to 3.46 depending on the method, age and sex; other studies, populations and insulin assays give other lines, and the score itself is imprecise. A HOMA-IR of 2.5 can count as insulin resistant in one study and normal in another, so the trend and the rest of the panel matter more than one number.
Insulin resistance is a condition in which the body's cells, mainly in muscle, liver and fat, respond poorly to insulin, the hormone that moves sugar from the blood into cells. To compensate, the pancreas makes more insulin, and that extra insulin keeps blood sugar normal, often for years. 12 That is why insulin resistance is easy to miss: a normal fasting glucose and A1C (a 3-month average of blood sugar) can sit alongside it, and NIDDK notes that clinicians may not test for it directly. 1 When the pancreas can no longer keep up, blood sugar climbs into prediabetes and then type 2 diabetes. 2 What to do next: if you have a fasting insulin, glucose, triglyceride or HDL result, bring the numbers to your clinician and ask how they read together, and whether an A1C or a 2-hour glucose test makes sense.
Symptoms of insulin resistance
NIDDK says people with insulin resistance and prediabetes usually have no symptoms. 1 The signs below are associations that make insulin resistance more likely; none of them diagnoses it, and many people with it have none.
- Dark, thick, velvety skin in the neck folds, armpits or groin (acanthosis nigricans)
- A waist over 35 inches for women or 40 inches for men
- Weight gain around the middle that is hard to shift
- Skin tags on the neck or in the armpits
- In women, irregular periods, excess hair growth or acne from PCOS
- High triglycerides and low HDL cholesterol
- A fasting glucose of 100 to 125 mg/dL or an A1C of 5.7 to 6.4%
- A raised ALT, a liver enzyme, from fatty liver
- High blood pressure
- A high fasting insulin with normal glucose
Get care the same day Seek same-day care for extreme thirst, frequent urination, unexplained weight loss, blurred vision with vomiting, deep fast breathing, or confusion, because these can signal very high blood sugar or diabetic ketoacidosis. Dark velvety skin that appears quickly over a wide area needs a prompt appointment, because MedlinePlus notes it can occasionally be linked to cancer. 8
Symptom lists drawn from NIDDK, MedlinePlus, NHLBI and the ADA 1893. Associations only, never a way to diagnose yourself.
Acanthosis nigricans is the most specific visible sign. MedlinePlus describes it as dark, velvety skin with visible markings in the armpits, groin and neck folds, often linked to "hormone imbalances that occur in diabetes and obesity, often called insulin resistance," and it often fades once the cause is found and managed. 8 The ADA lists acanthosis nigricans among the conditions associated with insulin resistance that count as a reason to screen for diabetes. 3
What is insulin resistance?
After a meal, insulin from the pancreas tells muscle, liver and fat cells to take up glucose (blood sugar). In insulin resistance those cells respond less, so more insulin is needed for the same effect. The resulting high insulin, called hyperinsulinemia, can itself make the resistance worse, which sets up a cycle. 2 StatPearls describes the consequences as high blood sugar, high blood pressure, abnormal blood fats, high uric acid, inflammation and a tendency to clot, and the conditions it leads to as metabolic syndrome, fatty liver and type 2 diabetes. 2 PCOS also sits on the same spectrum. 2
How insulin resistance turns into type 2 diabetes
Who gets insulin resistance and why
StatPearls calls insulin resistance mostly an acquired condition related to excess body fat, with some genetic causes. 2 NIDDK says researchers do not fully understand the cause and lists the risk factors below. 1 It is common: in 2021 about 97.6 million US adults had prediabetes, the later stage that insulin resistance leads to, and that number has barely moved in 15 years. 1
- Overweight, obesity or a large waist 1
- Age 35 or older, and a family history of diabetes 1
- Physical inactivity and smoking 1
- Certain racial and ethnic backgrounds, including African American, Hispanic or Latino, American Indian and Asian American people 13
- A history of gestational diabetes 1
- PCOS, Cushing's syndrome, acromegaly and sleep apnea 1
- Medicines such as glucocorticoids (steroids) 1
What test shows insulin resistance?
The clinical definition of insulin resistance remains elusive, as there is no generally accepted test for insulin resistance.
The gold standard is the hyperinsulinemic-euglycemic clamp, a research procedure that infuses insulin and glucose for hours to measure how fast the body clears sugar. It is not used in routine care. 2 Clinicians rely instead on surrogates: HOMA-IR, a second version called HOMA2, QUICKI, the triglyceride level and the triglyceride-to-HDL ratio. 2 In practice, the glucose tests then show whether insulin resistance has progressed to prediabetes or diabetes. 3
| Marker | What it shows | Typical cutoff | First-line or add-on |
|---|---|---|---|
| Fasting glucose | Blood sugar after 8 hours without food | 100 to 125 mg/dL prediabetes; 126 or more diabetes 3 | First-line |
| HbA1c | Average blood sugar over about 3 months | 5.7 to 6.4% prediabetes; 6.5% or more diabetes 3 | First-line |
| Triglycerides | Blood fat that rises with insulin resistance | 130 mg/dL or more flagged insulin resistance in overweight adults 4; 150 or more counts toward metabolic syndrome 9 | First-line (lipid panel) |
| HDL cholesterol | The protective cholesterol, often low with insulin resistance | Under 50 mg/dL in women, under 40 in men counts toward metabolic syndrome 9 | First-line (lipid panel) |
| Triglyceride-to-HDL ratio | A free calculation from the lipid panel | 3.0 or more in mg/dL (1.8 in mmol/L) 4 | First-line, no extra test |
| Fasting insulin | How hard the pancreas is working | Lab range 2.6 to 24.9 µIU/mL 7; 109 pmol/L (about 16 to 18 µIU/mL) best flagged resistance in one study 4 | Add-on |
| HOMA-IR | Insulin resistance estimate from fasting insulin and glucose | No official cutoff; 1.85 to 3.46 in one large study 6 | Add-on |
| 2-hour OGTT glucose | Glucose 2 hours after a 75 g sugar drink | 140 to 199 mg/dL impaired glucose tolerance; 200 or more diabetes 3 | Add-on; catches cases A1C misses |
| C-peptide | Made alongside insulin; a marker of the body's own insulin output | Lab range | Specialist; mainly in people on insulin 3 |
| ALT | Liver enzyme; raised in fatty liver | Lab range | First-line (liver panel) |
| Adiponectin | Hormone from fat tissue, lower with insulin resistance | No clinical cutoff | Research |
Fasting matters for most of these. Labcorp asks for a fasting sample for insulin, and the ADA defines fasting as no calories for at least 8 hours. 37 Insulin tests are not standardized between labs, which is why McLaughlin and colleagues at Stanford suggested the triglyceride level or the triglyceride-to-HDL ratio as the most practical screen: "In the absence of a standardized insulin assay," they wrote, those cut-points are the simplest way to find insulin-resistant overweight adults. 4 The lipid panel guide explains how triglycerides and HDL are reported.
Your cholesterol ratios, in context
Two ratios that say more than any single number. Nothing leaves your browser.

HOMA-IR: how it is calculated and what the cutoffs mean
HOMA-IR (homeostasis model assessment of insulin resistance) was published in 1985 by Matthews and colleagues. It uses the fact that fasting glucose and fasting insulin settle at a balance point set by how resistant the body is and how well the pancreas responds. 5 The common shortcut is fasting insulin in µIU/mL times fasting glucose in mg/dL, divided by 405 (or glucose in mmol/L divided by 22.5). The HOMA-IR calculator does the arithmetic. In the original study the score tracked the clamp closely (correlation 0.88), but its precision was low, with a coefficient of variation of 31%, so one result can mislead. 5
The cutoff problem is real. In 2,459 Spanish adults, a HOMA-IR line set at the 90th percentile was 3.46, while a line chosen to pick out people with metabolic syndrome was 2.05, and 1.85 in men without diabetes; in women the best cutoff changed with age. 6 The authors describe "great variability in the threshold" across studies. 6 Population, sex, age and the insulin assay all move the number, so labs and studies elsewhere use other lines.
Where an example HOMA-IR of 2.6 fallsHOMA-IR
HOMA-IR 1.5, 2, 2.5, 3 or 8.5: what the number means
These readings use the EPIRCE cutoffs above and assume fasting insulin in µIU/mL and glucose in mg/dL. 6 Another lab or study may draw the line elsewhere, and the original authors put the estimate's imprecision at about 31%. 5
- HOMA-IR of 0.8 to 1.5: below every common study cutoff; insulin sensitivity looks good. A very low value with high glucose is a different picture, low insulin output, worth raising with a clinician. 6
- HOMA-IR of 2 to 2.5: borderline. Above the 1.85 and 2.05 cutoffs, below the 3.46 one; the lipid panel, waist and A1C decide how much weight it carries. 6
- HOMA-IR of 3 to 3.5: insulin resistant by most study cutoffs, and close to the 90th-percentile line. 6
- HOMA-IR of 5: well above every common cutoff; fasting insulin is usually clearly raised, and glucose status deserves a check with A1C or an oral glucose tolerance test. 36
- HOMA-IR of 8.5: marked insulin resistance; fasting glucose at that level is often already in the prediabetes or diabetes range, so a diabetes workup usually follows. 3
HOMA-IR vs HbA1c: an early warning and a diagnostic test
How the insulin resistance markers read together
| Pattern | What it usually means |
|---|---|
| High fasting insulin, high HOMA-IR, normal glucose and A1C | Compensated insulin resistance: the pancreas is keeping up 2 |
| Triglycerides 130+ mg/dL or TG/HDL 3.0+, normal glucose | Likely insulin resistance in an overweight adult 4 |
| Fasting glucose 100 to 125 mg/dL or A1C 5.7 to 6.4%, high insulin | Prediabetes with ongoing insulin resistance 23 |
| Normal fasting glucose, 2-hour OGTT 140 to 199 mg/dL | Impaired glucose tolerance that a fasting test misses 3 |
| High HOMA-IR plus raised ALT | Insulin resistance with possible fatty liver; see fatty liver 2 |
| Large waist, high triglycerides, low HDL, high blood pressure and high fasting glucose together | Points toward metabolic syndrome 9 |
| High glucose with low or normal insulin and low C-peptide | The pancreas is not making enough insulin; the workup differs 3 |
Conditions linked to or mistaken for insulin resistance
Insulin resistance is a mechanism more than a stand-alone diagnosis, so the related conditions are its stages and companions. 2 Prediabetes is defined by glucose, not insulin; metabolic syndrome by waist, triglycerides, HDL, blood pressure and glucose; fatty liver by liver imaging and enzymes; and PCOS by cycles, androgens and ovarian findings. 239 A few conditions cause insulin resistance directly: Cushing's syndrome, acromegaly and steroid medicines, which a clinician considers when the picture is unusual, such as insulin resistance without excess weight. 1 High blood sugar with weight loss and low insulin points to the opposite problem, too little insulin, as in type 1 diabetes. 3
What helps insulin resistance: the evidence, graded
Lifestyle change has the strongest evidence, and the gains start quickly. In the Diabetes Prevention Program, 3,234 adults with raised glucose were assigned to a lifestyle program (goals of at least 7% weight loss and 150 minutes of activity a week), metformin, or placebo; over about 2.8 years, lifestyle cut new diabetes by 58% and metformin by 31%. 10 Prescription options are listed below as facts; whether any fits is a decision for your clinician with you.
| Approach | What the evidence shows | Strength | Cautions |
|---|---|---|---|
| Weight loss of 5 to 7% | Lowered the chance of type 2 diabetes in people at high risk 110 | Strong | Long-term maintenance is the hard part |
| Regular physical activity | Aerobic and resistance training both improve insulin action; the ADA recommends not letting more than 2 days pass between sessions 11 | Strong | Start gradually; ask a clinician before vigorous exercise with heart disease or diabetes complications |
| A single exercise session | Glucose uptake stays raised up to 48 hours after prolonged exercise; at least 60 minutes of even low-intensity activity improves insulin action for 24 hours or more in insulin-resistant adults 11 | Moderate | The effect fades within days without regular activity 11 |
| Breaking up sitting | Short walks after meals and light activity every 30 minutes improve glucose control 11 | Moderate | Long-term effects still being studied 11 |
| Healthy eating and sleep | NIDDK lists healthy eating, physical activity, weight management and sleep as the lifestyle that helps prevent insulin resistance 1 | Moderate | No single diet is required |
| Metformin (prescription) | Reduced new type 2 diabetes by 31% in the DPP; worked best in younger adults, people with obesity and women with past gestational diabetes 110 | Strong | Not FDA-approved for prediabetes or insulin resistance; stomach upset; long-term use can lower vitamin B12 |
| Magnesium (supplement) | A 2016 meta-analysis found a modest drop in HOMA-IR, mainly with 4 months or more of use, and no change in A1C or insulin 12 | Limited | Avoid with kidney disease unless a clinician advises |
| Berberine (supplement; no LifeFrom guide) | Studied in type 2 diabetes, not in insulin resistance itself: a 2022 meta-analysis of 37 small trials (about 80 people each on average) reported lower fasting glucose and A1C 14 | Limited | Not established for insulin resistance; product quality varies; can interact with other medicines, so tell your clinician, especially if you take diabetes medicine |
| Inositol (supplement; no LifeFrom guide) | Studied mainly in PCOS, with possible small metabolic effects; see the PCOS guide | Limited | Little evidence outside PCOS |
| Omega-3 (supplement) | A 2011 meta-analysis of 11 trials found no effect on insulin sensitivity 13 | Not supported | May have other uses, such as high triglycerides |
Monitoring and retesting
| What is checked | How often | Why |
|---|---|---|
| Fasting glucose or A1C | Yearly with prediabetes; at least every 3 years if normal, sooner with weight gain or symptoms 3 | Catches the move to prediabetes or diabetes |
| Lipid panel (triglycerides, HDL, TG/HDL ratio) | With routine checks | Free surrogate for insulin resistance 4; see the cholesterol ratio calculator |
| Fasting insulin and HOMA-IR | Optional; same lab, same fasting conditions, months apart 57 | Low precision means one change can be noise |
| Waist and blood pressure | At visits 9 | Metabolic syndrome criteria |
| ALT | With routine bloods 2 | Fatty liver screen |
| Vitamin B12 | Periodically on long-term metformin | Metformin can lower B12 |
Because HOMA-IR and fasting insulin bounce between draws, a trend across two or three results tells you more than one. See why trends beat single readings and the blood sugar guide for how fasting glucose, A1C and the OGTT fit together.
When to see a doctor
Outside those red flags, the ADA recommends diabetes screening from age 35 for everyone, and earlier for adults with overweight or obesity plus a risk factor such as a family history of diabetes, high blood pressure, PCOS, low HDL or high triglycerides, or acanthosis nigricans. 3 Any of those is a reason to ask your clinician about glucose testing.
Questions to ask your clinician
- Do my triglycerides, HDL and waist suggest insulin resistance, even with a normal glucose?
- Would a fasting insulin or HOMA-IR add anything for me, and which cutoff does your lab use?
- Should I have an A1C or a 2-hour oral glucose tolerance test?
- Do I have signs of fatty liver, and should my ALT be followed?
- Could any of my medicines, such as steroids, be adding to insulin resistance?
- How often should these tests be repeated, and what change would mean progress?
Related reading: prediabetes, metabolic syndrome, the HOMA-IR and fasting insulin marker pages, and how reference ranges work. This page is general education, not medical advice or a diagnosis. The clinician who knows your history reads your results and makes decisions with you.
Educational only: LifeFrom explains lab results and does not diagnose or treat insulin resistance. Extreme thirst, frequent urination, vomiting, deep fast breathing or confusion needs same-day care. Find the cause with a clinician before starting anything, including supplements.
Citations
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Insulin resistance and prediabetes. Last reviewed March 2025.
- Freeman AM, Acevedo LA, Pennings N. Insulin resistance. StatPearls. Treasure Island (FL): StatPearls Publishing; updated 2023.
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(Suppl 1):S27-S49.
- McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-809.
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
- Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47.
- Labcorp. Test 004333: Insulin. Reference range and patient preparation.
- MedlinePlus Medical Encyclopedia. Acanthosis nigricans. US National Library of Medicine.
- National Heart, Lung, and Blood Institute (NHLBI). Metabolic syndrome: diagnosis.
- Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079.
- Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016;111:272-282.
- Akinkuolie AO, Ngwa JS, Meigs JB, Djoussé L. Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials. Clin Nutr. 2011;30(6):702-707.
- Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol. 2022;13:1015045.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.





